Profil
Øyvind Kommedal was a Chief Medical Officer at Isentio AS, which he founded in 2005.
Dr. Kommedal is also the founder of Pathogenomix, Inc.
Aktive Positionen von Øyvind Kommedal
Unternehmen | Position | Beginn |
---|---|---|
Pathogenomix, Inc.
Pathogenomix, Inc. Medical/Nursing ServicesHealth Services Pathogenomix, Inc. engages in the direct sequencing analysis of clinical samples. Its RipSeq can analyze both NGS and Sanger direct-from-speciment sequencing files. The company was founded by Bjarte Karlsen, Oystein F. Saebo and Oyvind Kommedal and is headquartered in Santa Cruz, CA. | Gründer | - |
Ehemalige bekannte Positionen von Øyvind Kommedal
Unternehmen | Position | Ende |
---|---|---|
Isentio AS
Isentio AS Medical SpecialtiesHealth Technology Isentio AS provides deoxyribonucleic acid analysis tools for pathogen identification. Its platform RipSeq can analyze both next-generation sequencing and Sanger direct-from-specimen sequencing files. Its product focuses on analyzing mixed clinical samples. The firm also has a pathogen database called Vivet. The company was founded by Oystein Friestad Saebo and Øyvind Kommedal in 2005 and is headquartered in Bergen, Norway. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Isentio AS
Isentio AS Medical SpecialtiesHealth Technology Isentio AS provides deoxyribonucleic acid analysis tools for pathogen identification. Its platform RipSeq can analyze both next-generation sequencing and Sanger direct-from-specimen sequencing files. Its product focuses on analyzing mixed clinical samples. The firm also has a pathogen database called Vivet. The company was founded by Oystein Friestad Saebo and Øyvind Kommedal in 2005 and is headquartered in Bergen, Norway. | Health Technology |
Pathogenomix, Inc.
Pathogenomix, Inc. Medical/Nursing ServicesHealth Services Pathogenomix, Inc. engages in the direct sequencing analysis of clinical samples. Its RipSeq can analyze both NGS and Sanger direct-from-speciment sequencing files. The company was founded by Bjarte Karlsen, Oystein F. Saebo and Oyvind Kommedal and is headquartered in Santa Cruz, CA. | Health Services |